AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT SPRING BANK PHARMACEUTICALS, INC.Common Stock Purchase Warrant • April 13th, 2020 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) amends and restates, in its entirety, that certain Warrant for the purchase of up to [______] shares of the Common Stock (the “Warrant Shares”) of Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), issued to Pontifax Medison Finance ([Israel][Cayman]) L.P. or its assigns (the “Holder”), on September 19, 2019 (the “2019 Warrant”). The Holder is the holder of the 2019 Warrant, and the Holder, by its signature below, hereby agrees to the changed terms as set forth herein. This Warrant is being issued in consideration for the Lender Parties’ consent to a reduced Prepayment Charge and shorter period for the Prepayment Notice, as set forth in that certain Prepayment Notice and Payoff Letter dated as of April 8, 2020.
Prepayment Notice and Payoff LetterSpring Bank Pharmaceuticals, Inc. • April 13th, 2020 • Pharmaceutical preparations • New York
